The FDA recently accepted the New Drug Application (“NDA”) submission for CUTX-101 (copper histidinate for Menkes disease) for priority review with a PDUFA goal date of September 30, 2025. In December ...

The FDA recently accepted the New Drug Application (“NDA”) submission for CUTX-101 (copper histidinate for Menkes disease) for priority review with a PDUFA goal date of September 30 ...

This extension is a critical step in the regulatory process for the treatment of Menkes disease. These developments reflect Mustang Bio’s and Fortress Biotech’s ongoing efforts to advance their ...

Naeser M, Hugo T, Kobayashi M, et al. Modulation of cortical areas with repetitive transcranial magnetic stimulation to improve speech in aphasia. Neuroimage Human Brain Mapping Meeting, 2002: (abstr ...

Parkinson's disease is an illness that affects the part of your brain that controls how you move your body. Some people with Parkinson’s first notice weakness, difficulty walking, and stiff muscles.

Inspired by how a ... New Study Links Lower Proportions of Certain Sleep Stages to Brain Changes Associated With Alzheimer's Disease Mar. 31, 2025 — New research reveals that lower proportions ...

Liver disease is a broad term that can describe any issue that damages the liver and affects its function. Possible causes include infections, genetic conditions, autoimmune disorders, and cancer.